Ignazio Roiter

528 total citations
27 papers, 307 citations indexed

About

Ignazio Roiter is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Ignazio Roiter has authored 27 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Physiology. Recurrent topics in Ignazio Roiter's work include Bone health and treatments (7 papers), Prion Diseases and Protein Misfolding (7 papers) and Neurological diseases and metabolism (4 papers). Ignazio Roiter is often cited by papers focused on Bone health and treatments (7 papers), Prion Diseases and Protein Misfolding (7 papers) and Neurological diseases and metabolism (4 papers). Ignazio Roiter collaborates with scholars based in Italy, United States and Mexico. Ignazio Roiter's co-authors include Gianluigi Forloni, Fabrizio Tagliavini, Giorgio Da Rin, Ernesto De Menis, Veronica Redaelli, Michela Morbin, Roberto Chiesa, Flavio Villani, Ugo Lucca and Pietro Cortelli and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Neurology.

In The Last Decade

Ignazio Roiter

25 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignazio Roiter Italy 10 166 98 77 55 41 27 307
Laura de Diego-García Spain 11 119 0.7× 111 1.1× 86 1.1× 29 0.5× 14 0.3× 18 447
Graziella Rubino Germany 6 85 0.5× 163 1.7× 128 1.7× 14 0.3× 12 0.3× 12 417
E. J. O'Reilly United States 4 97 0.6× 112 1.1× 55 0.7× 217 3.9× 8 0.2× 5 374
Hanqing Ding China 9 72 0.4× 115 1.2× 68 0.9× 94 1.7× 15 0.4× 12 322
Eiichi Oguni Japan 8 120 0.7× 76 0.8× 191 2.5× 131 2.4× 21 0.5× 13 404
David A. Daley United States 5 114 0.7× 251 2.6× 268 3.5× 32 0.6× 7 0.2× 6 462
Erick Gómez‐Apo Mexico 9 76 0.5× 40 0.4× 74 1.0× 26 0.5× 36 0.9× 25 343
Makoto Sawada Japan 7 92 0.6× 142 1.4× 85 1.1× 11 0.2× 30 0.7× 8 347
Kathia Cordero United States 6 106 0.6× 17 0.2× 117 1.5× 21 0.4× 21 0.5× 7 326

Countries citing papers authored by Ignazio Roiter

Since Specialization
Citations

This map shows the geographic impact of Ignazio Roiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignazio Roiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignazio Roiter more than expected).

Fields of papers citing papers by Ignazio Roiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignazio Roiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignazio Roiter. The network helps show where Ignazio Roiter may publish in the future.

Co-authorship network of co-authors of Ignazio Roiter

This figure shows the co-authorship network connecting the top 25 collaborators of Ignazio Roiter. A scholar is included among the top collaborators of Ignazio Roiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignazio Roiter. Ignazio Roiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Restelli, Elena, Elena Quaglio, Alessandro Corbelli, et al.. (2021). Activation of Src family kinase ameliorates secretory trafficking in mutant prion protein cells. Journal of Biological Chemistry. 296. 100490–100490. 2 indexed citations
2.
Frontzek, Karl, Marco Losa, Georg Meisl, et al.. (2020). Autoantibodies against the prion protein in individuals with PRNP mutations. Neurology. 95(14). e2028–e2037. 10 indexed citations
3.
Forloni, Gianluigi, Ignazio Roiter, & Fabrizio Tagliavini. (2019). Clinical trials of prion disease therapeutics. Current Opinion in Pharmacology. 44. 53–60. 22 indexed citations
4.
Redaelli, Veronica, Edoardo Bistaffa, Gianluigi Zanusso, et al.. (2017). Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia. Scientific Reports. 7(1). 46269–46269. 39 indexed citations
5.
Iaccarino, Leonardo, Luca Presotto, Valentino Bettinardi, et al.. (2017). An in vivo 11C‐PK PET study of microglia activation in Fatal Familial Insomnia. Annals of Clinical and Translational Neurology. 5(1). 11–18. 9 indexed citations
6.
Forloni, Gianluigi, Mauro Tettamanti, Ugo Lucca, et al.. (2015). Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases. Prion. 9(2). 75–79. 46 indexed citations
7.
Forloni, Gianluigi, et al.. (2013). Therapy in Prion Diseases. Current Topics in Medicinal Chemistry. 13(19). 2465–2476. 31 indexed citations
8.
Albani, Diego, Ignazio Roiter, Sara Batelli, et al.. (2006). Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population. Neurobiology of Aging. 28(11). 1682–1688. 21 indexed citations
9.
Menis, Ernesto De, et al.. (1997). [Acute hyperparathyroidism associated with follicular carcinoma in the thyroid: possible role of juvenile cervical irradiation. Description of a case].. PubMed. 22(1). 19–22. 2 indexed citations
10.
Portaluppi, Francesco, Pietro Cortelli, Patrizia Avoni, et al.. (1995). Dissociated 24-Hour Patterns of Somatotropin and Prolactin in Fatal Familial Insomnia. Neuroendocrinology. 61(6). 731–737. 20 indexed citations
11.
Menis, Ernesto De, et al.. (1994). Increased Serum Levels of Carboxyterminal Propeptide of Type 1 Collagen (PICP) in Hyperthyroidism. Hormone and Metabolic Research. 26(7). 334–337. 8 indexed citations
12.
Menis, Ernesto De, et al.. (1992). Bone Turnover in Overt and Subclinical Hyperthyroidism Due to Autonomous Thyroid Adenoma. Hormone Research. 37(6). 217–220. 25 indexed citations
13.
Roiter, Ignazio, et al.. (1991). [Bone metabolism in primary hypothyroidism in the adult].. PubMed. 16(1). 7–10. 4 indexed citations
14.
Virgilio, Roberto Di, et al.. (1991). Clodronate Treatment Increases Serum Osteocalcin in Normocalcemic Osteolytic Bone Metastases. Oncology. 48(1). 54–57. 3 indexed citations
15.
Roiter, Ignazio, et al.. (1991). [Serum osteocalcin in hyperthyroidism].. PubMed. 5(2). 95–9. 2 indexed citations
16.
Roiter, Ignazio, et al.. (1991). Increased serum beta 2-microglobulin concentrations in hyperthyroid states.. Journal of Clinical Pathology. 44(1). 73–74. 14 indexed citations
17.
Lugaresi, Alessandra, Agostino Baruzzi, E Cacciari, et al.. (1987). LACK OF VEGETATIVE AND ENDOCRINE ORCADIAN RHYTHMS IN FATAL FAMILIAL THALAMIC DEGENERATION. Clinical Endocrinology. 26(5). 573–580. 19 indexed citations
18.
Conte, Nathalie, et al.. (1985). [Preoperative normalization of hypercalcemia, caused by parathyroid cancer, by intravenous administration of dichloromethylene diphosphonate].. PubMed. 9(1). 47–8. 1 indexed citations
19.
Cecchettin, M., et al.. (1984). Calcitonin in hepatoma and cirrhosis. European Journal of Endocrinology. 106(1). 109–111. 6 indexed citations
20.
Cecchettin, M., et al.. (1984). Serum Immunoreactive Calcitonin in Lung Cancer. Tumori Journal. 70(2). 137–140. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026